Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2017 call → NOThe question asks whether management conveys that the business is currently outgrowing the company's own size — that current activity, demand, or commitments are large relative to how small the company still is. Looking at the transcript, management discusses: - Revenue growth of 2% in Q3 - International auto-dimming mirror unit shipments up 12% - Full Display Mirror launches on multiple vehicles (GM, Subaru, Nissan) - Five OEM awards for FDM - New products at CES But does management convey a disproportion between the company's size and what's arriving? The company is a leading player in auto-dimming mirrors with ~90% market share historically. Management doesn't describe the company as small relative to what's happening. They describe growth, new product launches, and awards, but in a fairly ordinary way for a company of this size. The FDM launches are significant but management doesn't frame them as "disproportionately large relative to our small size." They talk about them as part of normal business development. The company is already a dominant player in its core market. There's no language about "this single customer could rival our entire company" or "we're small but what's coming is huge." Management seems to be describing a mature company with steady growth and new product adoption. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.